Yeast β-Glucans and PI3K/Akt Signaling in Obesity-Associated Type 2 Diabetes: Implications for Clinical Decision-Making
Obesity/type 2 diabetes (T2DM) is a major global health burden. Current management relies largely on pharmacological agents and insulin, while concerns regarding treatment-related adverse effects have increased interest in natural therapeutic alternatives and their evidence-based clinical evaluation. Yeast β-glucan is...